Vetrugno Luigi, Bove Tiziana, Orso Daniele, Barbariol Federico, Bassi Flavio, Boero Enrico, Ferrari Giovanni, Kong Robert
Department of Medicine, Anesthesia and Intensive Care Clinic, University of Udine, Udine, Italy.
Department of Anesthesia and Intensive Care, University-Hospital of Udine, Udine, Italy.
Echocardiography. 2020 Apr;37(4):625-627. doi: 10.1111/echo.14664. Epub 2020 Apr 15.
Lung ultrasound (LU) has rapidly become a tool for assessment of patients stricken by the novel coronavirus 2019 (COVID-19). Over the past two and a half months (January, February, and first half of March 2020) we have used this modality for identification of lung involvement along with pulmonary severity in patients with suspected or documented COVID-19 infection. Use of LU has helped us in clinical decision making and reduced the use of both chest x-rays and computed tomography (CT).
肺部超声(LU)已迅速成为评估感染2019新型冠状病毒(COVID-19)患者的一种工具。在过去两个半月(2020年1月、2月和3月上半月),我们使用这种方法来识别疑似或确诊COVID-19感染患者的肺部受累情况及肺部严重程度。肺部超声的使用有助于我们进行临床决策,并减少了胸部X光和计算机断层扫描(CT)的使用。